683 Capital Management »

Aclaris Therapeutics shares owned by 683 Capital Management

Quarter-by-quarter ownership of Aclaris Therapeutics (ACRS) shares owned by 683 Capital Management from 13F filings

Historical chart of 683 Capital Management investment in Aclaris Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aclaris Therapeutics held by 683 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aclaris Therapeutics by 683 Capital Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $539k 217k 2.48
2020-12-31 $299k 46k 6.48

More positions owned by 683 Capital Management

Palantir Technologies Cl A Put Option (PLTR)
Eli Lilly & Co. (LLY)
Tesla Motors Put Option (TSLA)
Capital One Financial (COF)
Madrigal Pharmaceuticals Put Option (MDGL)
Uniqure Nv SHS (QURE)
Alnylam Pharmaceuticals Put Option (ALNY)
Carvana Cl A (CVNA)
Insmed Com Par $.01 Put Option (INSM)
Uwm Holdings Corporation Com Cl A (UWMC)
Strategy Cl A New Put Option (MSTR)
Gxo Logistics Incorporated Common Stock (GXO)
Western Digital (WDC)
Novo-nordisk A S Adr Put Option (NVO)
United Therapeutics Corporation Put Option (UTHR)

View all positions for 683 Capital Management

Top funds holding Aclaris Therapeutics

BML Capital Management
Vivo Capital
Vanguard Group
BlackRock
Adage Capital Partners GP
Rock Springs Capital Management
Decheng Capital
Morgan Stanley
Geode Capital Management
D. E. Shaw & Co
Acadian Asset Management
Marshall Wace
Renaissance Technologies
Palo Alto Investors
Millennium Management

View all funds holding Aclaris Therapeutics